Hereditary Neuropathy Foundation, BioPontis deal

The foundation and alliance formed a JV to develop drugs to treat Charcot-Marie-Tooth (CMT) disease, which is a hereditary motor sensory neuropathy. BioPontis will manage the JV’s scientific execution...